Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 6 minute read General business news What Martin Marietta’s Quikrete exchange reveals about the future of U.S. cement and aggregates Martin Marietta secures regulatory approval for its Quikrete asset swap. See how $450M and 20M tons of aggregates reshape its strategy and stock. byPallavi MadhirajuOctober 3, 2025